(2017). Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
Cita Chicago Style (17a ed.)Decitabine, a DNA-demethylating Agent, Promotes Differentiation via NOTCH1 Signaling and Alters Immune-related Pathways in Muscle-invasive Bladder Cancer. 2017.
Cita MLA (8a ed.)Decitabine, a DNA-demethylating Agent, Promotes Differentiation via NOTCH1 Signaling and Alters Immune-related Pathways in Muscle-invasive Bladder Cancer. 2017.
Precaución: Estas citas no son 100% exactas.